NASDAQ : NIVF
NewGenIvf Group Limited — Key statistics
Healthcare · Medical Care Facilities · Thailand
Last price 1.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.27M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 9.55M |
| Enterprise Value | 5.69M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 9.82M |
| Shares Outstanding | 9.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 0.01% |
| Float | 9.78M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 8.66 |
| Forward PE | 0.00 |
| PS Ratio | 2.09 |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 5.21 |
| EV / Sales | 1.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.06 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.79 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 5.51% |
| Return on Assets (ROA) | -26.91% |
| Return on Invested Capital (ROIC) | -50.49% |
| Return on Capital Employed (ROCE) | -42.55% |
| Weighted Average Cost of Capital (WACC) | 9.47% |
| Revenue Per Employee | $53,238 |
| Profits Per Employee | $12,864 |
| Employee Count | 87 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 15.76 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 17.34 |
| 200-Day Moving Average | 387.68 |
| Relative Strength Index (RSI) | 22.47 |
| Average Volume (20 Days) | 2,243,676 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.47M |
| Short Previous Month | 70,041 |
| Short % of Shares Out | 24.97% |
| Short % of Float | 25.25% |
| Short Ratio (days to cover) | 0.09 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.63M |
| Gross Profit | 1.11M |
| Operating Income | -11.03M |
| Pretax Income | 951,299 |
| Net Income | 1.12M |
| EBITDA | -10.76M |
| EBIT | -11.03M |
| Earnings Per Share (EPS) | n/a |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 5.51M |
| Total Debt | 1.65M |
| Net Cash | 3.86M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 25.71M |
| Book Value Per Share | n/a |
| Working Capital | 618,325 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | n/a |
| Capital Expenditures | -181,842 |
| Depreciation & Amortization | 272,413 |
| Net Borrowing | n/a |
| Free Cash Flow | -14.82M |
| FCF Per Share | -$1.50 |
Margins
| Measure | Value |
|---|
| Gross Margin | 23.89% |
| Operating Margin | -238.22% |
| Pretax Margin | 20.54% |
| Profit Margin | 24.16% |
| EBITDA Margin | -232.34% |
| EBIT Margin | -238.22% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 11.54% |
| FCF Yield | -152.87% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 285.42% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 23, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.71 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |